Table 1. Pathological descriptors and patient demographics of prostate cancer patient cohort.
Total number of patients | 166 | ||
---|---|---|---|
% Recurrencea | 56 | ||
Median | Range | Average | |
Age Distribution (years) | 66 | 35 – 76 | 64 |
Time to Recurrence (days) | 256 | 0 – 3048 | 1797 |
PSA values | |||
pre-surgical (ng/ml) | 16.4 | 2 – 266 | 22.4 |
at time of recurrencea (ng/ml) | 0.2 | 0.07 – 12 | 0.72 |
last PSAb (ng/ml) | 0.1 | 0 – 1366 | 33.24 |
Vol. of Largest Cancer (cc) | 4.37 | 0.4 – 45 | 6.12 |
Total Cancer Volume (cc) | 4.8 | 0.4 – 45 | 6.58 |
Gleason Grade | |||
% Grade 3 | 60 | 0 – 98 | 55.7 |
% Grade 4 | 30 | 2 – 100 | 36.1 |
% Grade 5 | 0 | 0 – 90 | 3.9 |
% Intraductal | 0 | 0 – 60 | 4.3 |
% high grade (4/5) tumor | 35 | 2 – 100 | 40 |
Prostate weight (g) | 46 | 20 – 366 | 51.5 |
recurrence as determined by PSA >0.05 ng/mL after prostatectomy
last PSA: either at time of death or at the last 5 year follow-up visit